$17, complete, nothing held back

"I saw the FDA changed the warning on hormones. Does that mean they're safe now?"

You are getting this question. Here is the whole kit for answering it.

On November 10, 2025, the FDA removed most of the boxed warning from menopausal hormone therapy. Your patients saw the headline. What the action actually did is more specific, more useful, and more defensible than the coverage suggested.

What's in this one

• Twelve recorded findings, every one traceable to the FDA or HHS document
• Twenty patient questions with written answers — fourteen eligible for FAQ schema
• Twenty-five social posts, each marked and validated, each with its own image
• A side-by-side of the twenty-year argument against the government's own November 2025 language
• Five objection responses, including the political one
• Handout, one-pager, article, email, reel script, slides

What this kit will not let you say

Three things it holds the line on, because they're checkable in one click and they'd cost you credibility on everything else in the piece:

• The boxed warning is gone. The warnings are not. Cardiovascular and breast cancer language remains in the label for systemic products, and the endometrial boxed warning was retained for estrogen-alone.
• The FDA acted on approved products. It said nothing about compounded preparations. Extending the reasoning there is your inference, and the kit shows you how to make it visibly.
• The societies largely supported this. ACOG had advocated for removing the vaginal estrogen warning before the FDA acted. Writing this as vindication against them is inaccurate, and weaker than the truth.